Cambium Bio Limited Cambium Bio Limited

Cambium Bio Limited

CMB

Rank in Stocks #29933
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on... Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Share Price
$0.24638768
Last synced: 2026-11-12
Market Cap
$6.26M
Change (1 day)
-0.35%
Change (1 year)
-25.30%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for Cambium Bio Limited (CMB)
EPS as of June 2026 TTM: $-0.17
According to Cambium Bio Limited's latest financial reports, its current EPS (TTM) is $-0.17. At the end of 2025 the company had an EPS of $-0.14, an increase over its 2024 EPS of $-0.36.
EPS history for Cambium Bio Limited from 2011 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.17 20.93%
2025 $-0.14 -61.67%
2024 $-0.36 -50.80%
2023 $-0.73 -24.64%
2022 $-0.97 -239.47%
2021 $0.70 -397.23%
2020 $-0.23 -88.15%
2019 $-1.98 9.60%
2018 $-1.81 -250.43%
2017 $1.20 -197.15%
2016 $-1.24 -45.18%
2015 $-2.26 -51.09%
2014 $-4.61 89.04%
2013 $-2.44 42.10%
2012 $-1.72 79.92%
2011 $-0.95 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$-0.89 425.69%
US
$15.66 -9,349.85%
US
$-7.07 4,076.02%
US
$-5.29 3,024.63%
AU
$12.73 -7,620.50%
BE

Questions about Cambium Bio Limited's earnings per share (EPS)

What is Cambium Bio Limited's earnings per share (EPS)?

Cambium Bio Limited's earnings per share (EPS) over the last twelve months is $-0.17, as of Jun 2026.

What was Cambium Bio Limited's earnings per share (EPS) in 2025?

In 2025, Cambium Bio Limited's earnings per share (EPS) was $-0.14, compared with $-0.36 in 2024.

How has Cambium Bio Limited's earnings per share (EPS) changed since 2020?

From 2020 to 2025, Cambium Bio Limited's earnings per share (EPS) was highest in 2021 ($0.70) and lowest in 2022 ($-0.97).

How does Cambium Bio Limited's earnings per share (EPS) compare with similar companies?

Cambium Bio Limited's earnings per share (EPS) ($-0.17) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.